David Len Elion, Ph.D.
Rebecca Cook lab
I study RIG-I agonists as a potential way to increase breast tumor cell killing, while also promoting anti-breast tumor immunity in the tumor microenvironment
Recent Papers: Cancer Res. 2018 Nov 1;78(21):6183-6195
How Vanderbilt made an impact: The Initiative for Maximizing Student Diversity (IMSD) program, and the T32 Microenvironmental Influences in Cancer training grant gave me the resources, knowledge, and training to succeed in graduate school.
Next plans: Postdoctoral Fellowship at UCSF